The rally was real, but the foundation remained fragile.
As summer trading resumed, Wall Street offered a tentative exhale — futures edging upward, a handful of resilient stocks finding footing above key technical levels, and a week-old rally carrying cautious momentum into Monday morning. Yet the optimism was tempered by the knowledge that markets rarely heal cleanly: many stocks remained deeply wounded from months of selling, and the volume surge that had powered Friday's close owed more to index rebalancing than to genuine investor conviction. The question hanging over every gain was an old one — whether this represented a true turning of the tide, or simply a pause in a longer reckoning.
- Nasdaq futures climbed 0.5% Monday morning, extending a Friday surge of 3.3% that capped a week-long rally — but the enthusiasm carried a quiet asterisk.
- The late-session volume spike that fueled Friday's gains was traced to index rebalancing, not organic buying, raising doubts about the rally's underlying strength.
- Six stocks — including Johnson & Johnson, AutoZone, and Eli Lilly — emerged as technical bright spots, each holding near or above key buy points in a market still littered with damaged charts.
- Tesla rallied nearly 4.5% Friday and continued higher Monday, yet remained roughly 40% below its November peak, a reminder that momentum and recovery are not the same thing.
- Apple and Microsoft joined the advance but both sat approximately 23% below their 52-week highs, still navigating the long road back from significant structural damage.
- Market observers urged measured re-entry: the rally was real, the momentum present, but the foundation — with major indexes still near yearly lows — remained fragile.
Monday morning arrived with modest optimism. Dow Jones futures edged up 0.2%, S&P 500 futures climbed 0.3%, and Nasdaq 100 futures advanced 0.5% — a continuation of the energy that had carried the previous week, when the Nasdaq surged 7.5% in five sessions. Beneath the surface, however, the picture was more complicated: the market remained scarred from earlier losses, many stocks were still badly damaged, and Friday's late volume surge had been driven by index rebalancing rather than genuine buying conviction.
Six stocks stood out as candidates to watch. Johnson & Johnson had broken above a double bottom buy point of 181.84 and was holding in buy range, backed by an IBD Composite Rating of 95 out of 99. Merck had climbed back above its 50-day moving average and was approaching a flat base buy point. AutoZone received a Goldman Sachs upgrade from neutral to buy, with analysts arguing the auto parts retailer was defensively positioned for the current environment — and the stock had already broken out of a cup-with-handle pattern. Bristol Myers Squibb, Eli Lilly, and Quanta Services rounded out the watchlist, each trading near or within technical buy zones.
Tesla told a different story. The electric vehicle maker had rallied nearly 4.5% Friday and continued higher Monday despite a price-target cut, with second-quarter delivery figures expected later in the week. Yet the stock remained roughly 40% below its November peak and was still trading well beneath both its 50-day and 200-day moving averages — a sign that the longer-term trend had not yet mended.
Apple and Microsoft were also moving higher, each gaining meaningfully on Friday and extending those gains Monday morning. But both remained approximately 23% below their 52-week highs, still working their way back from months of selling pressure. Participation in a rally and recovery from damage, the market was quietly insisting, are two very different things.
The broader backdrop stayed cautious. The 10-year Treasury yield ticked up to 3.18%, oil hovered just above 108 dollars a barrel, and major indexes remained near their lows for the year. The rally was real, the momentum present — but for investors watching these stocks and this market, the central question remained unanswered: was this the beginning of a sustained recovery, or simply a relief bounce in a longer downtrend?
Monday morning arrived with modest optimism. Dow Jones futures had edged up 0.2% against fair value, while the S&P 500 futures climbed 0.3% and the Nasdaq 100 futures advanced 0.5%—a continuation of the momentum that had carried the previous week. The Nasdaq had surged 3.3% on Friday alone, finishing the week up 7.5%, and that energy seemed to be carrying into the new trading session. Yet beneath the surface gains lay a more complicated picture: the market remained scarred from earlier losses, many stocks were still badly damaged, and the volume that had driven Friday's final surge had come suspiciously late, triggered by index rebalancing rather than organic buying conviction.
Six stocks were positioned as candidates to watch in this emerging rally. Johnson & Johnson, the pharmaceutical giant, had broken above a double bottom buy point of 181.84 on Friday's 1.5% move and was holding in buy range Monday morning, though shares were flat. The company's IBD Composite Rating of 95 out of 99 signaled strong fundamental and technical health. Merck, another drug leader, had climbed back above its 50-day moving average and was closing in on a flat base buy point of 95.02 after a four-day winning streak. AutoZone had received a significant boost when Goldman Sachs upgraded the stock from neutral to buy with a 2,296 price target, arguing the company was defensively positioned for the current environment. The auto parts retailer had already broken out past a cup-with-handle pattern on Friday and was trading in buy range. Bristol Myers Squibb, which had been named IBD Stock of the Day on Friday, was just above its flat base buy point of 78.72 after advancing 1.6%. Eli Lilly, tracked on IBD's SwingTrader list, had reclaimed its 50-day line and was trading near new highs, within the 5% buy zone that extended to 329.81. Quanta Services, on the IBD Leaderboard watchlist, was tracing a cup-with-handle pattern with a buy point of 138.56 and had climbed back above its 50-day line.
Tesla presented a different kind of story. The electric vehicle maker had rallied nearly 4.5% on Friday, snapping a two-day losing streak, and was up nearly 2% early Monday despite a price-target cut from Mizuho. The company was expected to report second-quarter deliveries late in the week, with analyst estimates centered around 273,000 vehicles, though forecasts ranged from 249,000 to 323,000. Tesla had delivered 310,048 vehicles in the first quarter. Yet the stock remained deeply underwater from its November peak of 1,243.49—down roughly 40%—and was still trading well below both its 50-day and 200-day moving averages, a sign that the longer-term trend remained broken.
Among the Dow's technology leaders, Apple and Microsoft were both moving higher Monday morning. Apple had gained 2.45% on Friday and was at its highest level since June 9, but the stock remained about 23% below its 52-week high and was still far from its 200-day moving average. Microsoft had surged 3.4% on Friday and was now sitting right at its 50-day line after hitting a 52-week low on June 14. Like Apple, it was roughly 23% off its 52-week high. Both stocks were participating in the rally, but both were still working their way back from significant damage.
The broader market backdrop remained cautious. The 10-year Treasury yield had ticked up to 3.18% Monday morning, continuing its climb from Friday's 3.12%, though it had pulled back from the mid-June peak above 3% that represented the highest level since April 2011. Oil prices were attempting to rebound after recent losses, with West Texas Intermediate crude trading just above 108 dollars a barrel—a far cry from the early March peak above 130 dollars. Among exchange-traded funds, the Nasdaq 100 tracker Invesco QQQ Trust had moved up 0.6%, while the SPDR S&P 500 ETF had gained 0.5%.
The cautionary note from market observers was clear: investors should move back into stocks carefully. Friday's surge in volume had come in the final minutes of trading, driven by index changes rather than conviction buying. The major indexes remained near their lows for the year. Many individual stocks had been badly damaged by the earlier selloff and had not yet recovered. The rally was real, the momentum was present, but the foundation remained fragile. For investors watching these six stocks and the broader market, the question was whether this was the beginning of a sustained recovery or merely a relief bounce in a longer downtrend.
Citas Notables
Investors should note that volume had been running lower prior to the final minutes of trading, when index changes caused trading to soar. This is a reason to exercise extra caution, and get back into stocks carefully.— IBD's The Big Picture column
AutoZone is defensively positioned in the current environment.— Goldman Sachs, upgrading AutoZone to buy
La Conversación del Hearth Otra perspectiva de la historia
Why should anyone care about six stocks on a Monday morning when the whole market is still down so much from where it was?
Because rallies don't start from the top. They start from moments like this—when the worst has already happened and a few strong names begin to signal that the selling might be over. These six stocks broke above key technical levels on Friday. That matters.
But you mentioned the volume was suspicious. Late-day index rebalancing, not real buying. Doesn't that undermine the whole thing?
It does. That's exactly why the warning exists. The rally is real in the sense that prices moved up. But it's fragile because it wasn't built on broad conviction. It was built on mechanical trading. That's why you move carefully, not all at once.
Tesla is up 2% Monday but down 40% from its peak. Why would anyone buy it now?
Because the question isn't where it was. The question is where it's going. If Tesla reports strong deliveries this week and the stock breaks above its moving averages, then the technical picture changes. Right now it's just a stock that bounced. It could be the start of something, or it could fade.
And the Treasury yield going up to 3.18%—doesn't that make stocks less attractive?
It does, in theory. Higher rates mean future earnings are worth less in today's dollars. But the market had already priced in a lot of pain. Sometimes a stabilization in rates, even at higher levels, is enough to let buyers step back in. The real question is whether rates keep climbing or hold here.
So what are you actually watching for?
Whether these six stocks hold their buy points. Whether the Nasdaq can sustain this momentum into the rest of the week. Whether Tesla's delivery numbers meet expectations. And whether the volume on any further rally comes from real buying or more mechanical index rebalancing. That's the difference between a real recovery and a false start.